The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. C4 Therapeutics Inc’s current trading price is -61.70% away from its 52-week high, while its distance from the 52-week low is 329.25%. The stock’s price range for this period has been between $1.06 and $11.88 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.03 million for the day, a number notably higher than the average daily volume of 1.02 million over the last three months.
In terms of market performance, C4 Therapeutics Inc had a fairly even. The highest value for the stock in the past year was $11.88 on 03/04/24, and the lowest value was recorded at $1.06 on 12/06/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
C4 Therapeutics Inc (CCCC) has experienced a quarterly decline of -29.24% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 321.18M and boasts a workforce of 145 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 5.86, with a change in price of -0.45. Similarly, C4 Therapeutics Inc recorded 1,126,860 in trading volume during the last 100 days, posting a change of -9.00%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CCCC stands at 0.28. Similarly, the long-term debt-to-equity ratio is also 0.25.
CCCC Stock Stochastic Average
C4 Therapeutics Inc’s raw stochastic average for the past 50 days is presently 21.52%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 26.49%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 19.90% and 16.67%, respectively.
CCCC Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -19.47% this year. Over the last six months, there has been a stronger performance of -8.63%. The price of CCCC leaped by -22.88% during the last 30 days period. For the last 5-days stocks have improved 12.35%.
